Evidence map›Paper›PMID 39886784›Full record

ArticleCurrent medicinal chemistry2025

Clinicopathological and

Mohammed Ahmed Alkireidmi, Mohamed Gamil Mehanna, Mirza Rafi Baig, Fahad Ahmed Al-Abbasi, Naif Abdullah Raddah Almalki, Turky Omar Asar, Ahmad Firoz, Vikas Kumar, Firoz Anwar

Abstract read
PubMed Publisher
In one paragraph

Article in Current medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohammed Ahmed AlkireidmiDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Mohamed Gamil MehannaDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Mirza Rafi BaigDepartment of Clinical Pharmacy & Pharmacotherapeutics, Dubai Pharmacy College for Girls, Dubai Medical University, Dubai, United Arab Emirates.
Fahad Ahmed Al-AbbasiDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Naif Abdullah Raddah AlmalkiDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Turky Omar AsarDepartment of Biology, College of Science and Arts at Alkamil, University of Jeddah, Jeddah, Saudi Arabia.
Ahmad FirozDepartment of Biological Science, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Vikas KumarNatural Product Discovery Laboratory, Department of Pharmaceutical Sciences, Shalom Institute of Health and Allied Sciences, SHUATS, Prayagraj, India.
Firoz AnwarDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.

Funding

Ministry of Education and King Abdulaziz University, DSR, Jeddah. Saudi Arabia 420-130-1443
6 · The paper itself

Abstract

backgroundInfertility was often considered a female issue, but male infertility emerged significantly after the COVID-19 pandemic. Hence, assessments are crucial for planning policies on health care and family planning and reasons thereof post vaccinations. MATERIALS AND

methodsThe present study was a case-control, dual-centers, prospective study with normal sperm parameters. Semen samples collected by masturbation for idiopathic reasons were conducted at King Abdulaziz University with 133 samples, followed by molecular modeling via interaction between IZUMO1, Alpha2A adrenergic receptor, and Fibroblast growth factor receptor 2 protein with IgA antibody produced post vaccination/infection. RESULTS AND DISCUSSION: The infertile males under 30 (21%), 31-40 (50%), 41-50 (24%) and over 50 (5%), with altered sperm motility grades are A (8.45%), B (11.1%), C (15.8%), and D (59.8%) were reported. Liquefaction times range from 36 to 30 minutes by age, with abnormal sperm percentages between 43.85% and 46.33%. Protein molecular interaction between IZUMO1, Alpha2A adrenergic receptor, and Fibroblast growth factor receptor 2 protein with IgA antibody shows cumulative length of 25.354 Å, 39.049 Å, and 41.999 Å, respectively, with significant interaction between atoms chain, amino acid, marked variation in bond length.

conclusionMale infertility peaks at 31-40 years, with lowering in men aged 41-50 years, IgA antibody reduced sperm motility, causing immunogenic infertility exacerbated post-COVID-19 vaccination or infection. Interaction of IgA and various receptors produced stable interactive molecules of IgA and proteins on sperm, affecting motility, aliquefication, and abnormal sperm percentage disturbing the normal dynamics of sperm cells opening a new dimension of infertility among males.

Indexed as

COVID-19COVID-19 VaccinesInfertility, MaleSpermatozoaAdultAge FactorsCase-Control StudiesComputer SimulationHumansImmunoglobulin AImmunoglobulinsMaleMembrane ProteinsMiddle AgedProspective StudiesSARS-CoV-2COVID-19 VaccinesImmunoglobulin AImmunoglobulinsMembrane Proteinsage trendsantibodies.anti-spermClinicopathologicalin silico assaymale infertility

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.